window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : February 10, 2026

  • News
  • About Us
Contact Us

automation

  • Clinical Development,Clinical studies,Clinical Trials,Data Management,Digital Health,Drug Development,Regulatory Affairs,Technology and platforms

    CluePoints: how proactive oversight and AI are reshaping clinical trial data management

    Dan Beaudry, market owner for risk-based quality management (RBQM) at [...]

    January 7, 2026
  • Facilities and infrastructure,Logistics and distribution,Market Access & Commercialization,Packaging

    Tjoapack expands US site to bolster packaging capacity and cold chain capabilities

    Tjoapack is expanding its US operations with a major build [...]

    December 10, 2025
  • Genomics and sequencing,Partnerships & Funding,Single Cell analysis,Technology and platforms

    SPT Labtech and Alithea Genomics partner to automate ultra sensitive single-cell RNA sequencing

    SPT Labtech has partnered with Alithea Genomics to automate single-cell [...]

    November 6, 2025
  • Artificial Intelligence,Biotech,CDMOs & Manufacturing

    Pharma leaders on AI, automation, and ESG: How CDMOs are reshaping development at CPHI Frankfurt 2025

    At another of this year’s CPHI Frankfurt 2025 roundtable, executives [...]

    November 6, 2025
  • Genomics and sequencing,Research & Development

    SPT Labtech and Agilent launch automated target enrichment workflows for genomic sequencing

    SPT Labtech and Agilent Technologies have introduced automated target enrichment [...]

    January 26, 2026
  • Cell & Gene Therapy,Medical devices,Movers & Shakers,Partnerships & Funding,Pharmaceuticals and therapeutics,Technology and platforms

    Robots could slash cost of cell therapy by 74%, opening doors to wider access

    Multiply Labs and Universal Robots pioneer automated manufacturing for personalised [...]

    August 25, 2025
  • Artificial Intelligence,Biologics & Biosimilars,CDMOs & Manufacturing,Market Access & Commercialization,Research & Development

    Nearly three-quarters of scientists expect a recession – but most still plan to spend LINUS survey reveals

    Despite political and economic pressures, researchers remain focused on collaboration, [...]

    July 31, 2025
  • Artificial Intelligence,Technology and platforms

    Retab launches developer-first document AI platform and raises $3.5M in pre-seed funding

    Retab, a startup aiming to simplify document automation for developers, [...]

    July 30, 2025
  • Artificial Intelligence,Biologics & Biosimilars,CDMOs & Manufacturing,Partnerships & Funding,Research & Development,Technology and platforms

    AI-powered bioreactor project aims to transform biologics manufacturing

    A Canada–UK collaboration is developing an AI-driven bioreactor platform designed [...]

    July 25, 2025
  • Drug Development,Research & Development,Technology and platforms

    Sygnature Discovery upgrades high-throughput chemistry platform following £1 million investment

    Sygnature Discovery has completed a major upgrade of its high-throughput [...]

    July 23, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • SpotitEarly partners with Fox Chase Cancer Center to advance breath-based cancer detection trials
    Categories: Artificial Intelligence, Clinical Trials, Diagnostics, Oncology
  • DFE Pharma launches EcoLact 2030 to cut CO₂ emissions across lactose excipients
    Categories: Ingredients, Manufacturing, Pharmaceuticals and therapeutics, Sustainability
  • Cereno Scientific broadens CS014 development focus to pulmonary hypertension linked to interstitial lung disease
    Categories: Clinical Development, Clinical Trials, Rare Diseases, Respiratory
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top